A carregar...
PHARMACOGENETICS AND PHARMACOGENOMICS OF TARGETED THERAPEUTICS IN CHRONIC MYELOID LEUKEMIA
The advent of targeted therapeutics has greatly improved outcomes of chronic myeloid leukemia (CML) patients. Despite increased efficacy and better clinical responses over cytotoxic chemotherapies, many patients receiving targeted drugs exhibit a poor initial response, develop drug resistance, or un...
Na minha lista:
| Publicado no: | Mol Diagn Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693681/ https://ncbi.nlm.nih.gov/pubmed/28698977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40291-017-0292-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|